-
Feinberg Rises in Medical School Rankings
Feinberg has moved up two spots to become the 17th best medical school in the country for research, according to the latest U.S. News & World Report rankings.
-
Medical Students Celebrate World Kidney Day with the Division of Nephrology
First-year medical students celebrated World Kidney Day with faculty members and staff in the Division of Nephrology and with patients who have kidney disease.
-
Rescuing Damaged Neurons in Parkinson’s Disease
Northwestern Medicine scientists shed light on a hallmark of Parkinson’s disease that has been poorly understood, the buildup of a protein called α-synuclein in the brain.
-
Testing a New Therapy for Advanced Blood Cancer
A recent clinical trial conducted by Northwestern Medicine investigator Seema Singhal, MD, showed that the drug daratumumab is a safe and effective treatment for patients with advanced multiple myeloma.
-
Uncovering Genetic Basis of Cilia Motility and Polarity
Scientists discovered that a specific gene that starts to build a link between cilia motility and cell polarity in a recent study.
-
Physician Assistant Students Explore Correctional Medicine at Cook County Jail
Second-year physician assistant students recently completed a correctional medicine rotation at Cook County Jail, learning about the correctional medicine specialty.
-
Northwestern Simulation Opens its Doors
Northwestern Simulation in the Department of Medical Education invited guests to participate in hands-on demonstrations and a tour of their center at an open house on March 3.
-
Crucial Step in Red Blood Cell Development Discovered
New Northwestern Medicine research has revealed a surprising phenomenon behind the production of red blood cells: an opening that forms on the nuclear membrane to condense chromatin.
-
Low Vitamin D Predicts Aggressive Prostate Cancer
A new Northwestern Medicine study showed that deficient vitamin D blood levels in men can predict aggressive prostate cancer.
-
Examining New Breast Cancer Therapy
A phase III clinical trial tested the effectiveness of a combination of two drugs and found they may be an effective and safe treatment for patients with metastatic breast cancer.
-
Remembering Neuroscientist Aryeh Routtenberg
Aryeh Routtenberg, PhD, a longtime professor of Physiology at Feinberg, died Feb. 27.
-
Discussing the Zika Virus
The Institute for Public Health and Medicine hosted a seminar on the epidemiology and virology of Zika virus, risks associated for travelers and possible links between the virus and microcephaly in infants.
-
New Northwestern Institute Commits to Improving LGBT Health
The Institute for Sexual and Gender Minority Health and Wellbeing is the first research institute in the United States established university-wide that is focused exclusively on LGBT health.
-
Medical Student Receives Fellowship to Study Smoking Cessation in India
Smitha Sarma, third-year medical student, will study tobacco cessation approaches in Kerala, India, as a Fogarty Fellow.
-
New Intravaginal Ring Enhances Drug Delivery
A team left by Northwestern Medicine biomedical engineer Patrick Kiser, PhD, designed an intravaginal ring equipped with a novel drug release mechanism that enables the delivery of a diverse array of drugs for extended durations.
-
Assessing Steroid Treatment for Women at Risk for Late Preterm Delivery
A new study suggests giving the steroid betamethasone to women at risk for late preterm delivery significantly reduces the rate of neonatal complications.
-
PhD Student Explores Molecular Processes Behind Heart Cell Growth and Regeneration
MPH/PhD student Erin Lambers identified mechanisms that shed light on how cardiac cells develop from stem cells, which can help scientists better understand how the heart grows and regenerates.
-
Medical Students Develop App to Enhance Learning
Second-year medical students built a web app to help teach fellow classmates and prepare for upcoming exams.
-
Nanoparticles Destroy Cancer With Mechanical Force
By rotating special magnetic nanoparticles injected into brain tumors, a team of scientists led by Northwestern Medicine neurosurgical oncologist Maciej (Matt) Lesniak, MD, successfully damaged tumor cells in animal models.
